Transplant Genomics Grants Four Institutes Early Access to Kidney Transplant Test | GenomeWeb

This article has been updated to correct an explanation of how the test works versus the current standard of care.

NEW YORK (GenomeWeb) – Molecular diagnostics firm Transplant Genomics today announced that its TruGraf post-kidney transplant blood tests have been accepted for use by four transplant centers under an early-access program — California Pacific Medical Center, the Henry Ford Health System, Houston Methodist Hospital, and the University of Wisconsin.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Biomedical research projects are generating a ton of data that still needs to be analyzed, NPR reports.

Theranos is retiring some of its board members, including Henry Kissinger and George Shultz, Business Insider reports.

The heads of 29 scientific societies and some 2,300 researchers call on President-elect Donald Trump to rely on and support science in two separate letters.

In Science this week: genetically modified flu virus could be key to new live vaccines, and more.